Frank Holms
Hamm, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 03, 2020
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial.
Journal: International journal of cancer
Published: June 19, 2018
A Submammarian Approach for Cosmetically Improved Implantation of Deep Brain Stimulation Generators.
A Submammarian Approach for Cosmetically Improved Implantation of Deep Brain Stimulation Generators.
Journal: World neurosurgery
Published: July 15, 2017
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2017
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 05, 2015
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 17, 2014
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy.
Journal: Breast care (Basel, Switzerland)
Published: December 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026